Bladder Cancer

Immunotherapy Just After Chemo May Allow Some Patients with Bladder Cancer to Maintain Health Benefits

September 30th 2020, 9:00pm

Article

Patients with advanced or metastatic bladder cancer, after responding to initial treatment with chemotherapy, may preserve their health improvements by starting immunotherapy immediately.

There is Help for Patients Dealing with Sexual Side Effects After Prostate, Bladder Cancer Treatment

September 30th 2020, 3:00pm

Article

After treatment for bladder or prostate cancer, many survivors confront permanent sexual side effects. The good news is that treatments and psychological support are available.

FDA Approves Bavencio as Frontline Maintenance Therapy in Advanced Bladder Cancer

July 1st 2020, 3:39pm

Article

The Food and Drug Administration approved Bavencio as a first-line maintenance therapy for patients with locally advanced or metastatic urothelial carcinoma.

Infigratinib Appears Active Across All Lines of Treatment in Patients With Advanced Bladder Cancer

June 16th 2020, 7:45pm

Article

"These results suggest that infigratinib has activity in patients with advanced urothelial carcinoma, regardless of the line of treatment,” says lead study author Dr. Yung Lyou.

Cabometyx-Tecentriq Combination Produces 'Encouraging Clinical Activity' in Previously Treated Bladder Cancer

June 12th 2020, 5:00pm

Article

At a median follow-up of 19.7 months, patients who received the combination achieved an objective response rate (the proportion of patients who had a complete or partial response to treatment) of 27%.

Bavencio Soon After Chemotherapy Improves Survival in Patients with Advanced Bladder Cancer

May 29th 2020, 5:00pm

Article

The immunotherapy Bavencio improves survival when given as a maintenance treatment in patients whose advanced urothelial carcinoma did not progress on platinum-based chemotherapy.

Don't Ignore the Warning Signs of Cancer, Even During a Pandemic

May 19th 2020, 5:00pm

Video

Even amid stay at home orders to mitigate the spread of the coronavirus, listen to your body and speak to your healthcare professionals when you are worried about a potential for cancer.

What Patients with Bladder Cancer Can Do When COVID-19 Impacts Their Care

May 16th 2020, 6:00pm

Video

COVID-19 has drastically changed the landscape for patients with bladder cancer, but the new challenges are not insurmountable. CURE had the chance to interview the co-founder of the Bladder Cancer Advocacy Network to discuss these changes.

How One Organization is Honoring Bladder Cancer Awareness Month During the COVID-19 Pandemic

May 14th 2020, 10:00pm

Video

Amid the COVID-19 pandemic, the Bladder Cancer Advocacy Network is honoring Bladder Cancer Awareness Month in a slightly different way from previous years.

FDA's Jelmyto Approval Offers Patients 'Very Sorely Needed' Treatment Option

April 22nd 2020, 10:00pm

Article

The Food and Drug Administration’s approval of Jelmyto (mitomycin gel]) in low-grade upper tract urothelial cancer offers patients a much-needed treatment option, according to one expert.

x